Provided by Tiger Trade Technology Pte. Ltd.

Parnell Pharmaceuticals Holdings Ltd.

0.0800
0.0000
Volume:- -
Turnover:- -
Market Cap:1.44M
PE:-2.24
High:0.0800
Open:0.0800
Low:0.0800
Close:0.0800
52wk High:0.0800
52wk Low:0.0800
Shares:18.02M
Float Shares:18.02M
Volume Ratio:0.01
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0356
EPS(LYR):-0.0356
ROE:32.10%
ROA:6.47%
PB:-0.06
PE(LYR):-2.24

Loading ...

Company Profile

Company Name:
Parnell Pharmaceuticals Holdings Ltd.
Exchange:
EXPERT
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Parnell Pharmaceuticals Holdings Ltd, a commercial-stage pharmaceutical company, focuses on developing, manufacturing, and marketing animal pharmaceutical products worldwide. The company operates through four segments: Companion Animal, Production Animal - U.S., Production Animal - Rest of World, and Manufacturing Operations. It markets various products, including estroPLAN and GONAbreed reproductive hormone products for enhancing cattle breeding performance; Zydax for the treatment of osteoarthritis (OA) in dogs and horses; and Glyde, a nutraceutical product for the treatment of OA, as well as Parnell PROcept, which adds an additional injection of estroPLAN after the first injection. The company also offers mySYNCH, a digital tool to help veterinarians and producers optimize reproduction and maximize economic gains. Parnell Pharmaceuticals Holdings Ltd was incorporated in 2009 and is headquartered in Alexandria, Australia.